Resolve Therapeutics, LLC
3Patents
3Active
3Granted
51Portfolio score
Filing activity: Oct 31, 2014 → Dec 23, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10988745B2 | Therapeutic nuclease-albumin fusions and methods | Chemistry; Metallurgy | 6 | Active |
| US12163165B2 | Nucleic acid molecules encoding nuclease-albumin fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US12077790B2 | Optimized binuclease fusions and methods | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.